Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 5 publications
Napabucasin Plus FOLFIRI in Patients With Previously Treated Metastatic Colorectal Cancer: Results From the Open-Label, Randomized Phase III CanStem303C Study.
Journal: Clinical colorectal cancer
Published: September 09, 2022
Ipilimumab, Pembrolizumab, or Nivolumab in Combination with BBI608 in Patients with Advanced Cancers Treated at MD Anderson Cancer Center.
Journal: Cancers
Published: January 29, 2022
Mass balance and pharmacokinetics of an oral dose of 14 C-napabucasin in healthy adult male subjects.
Journal: Pharmacology research & perspectives
Published: June 29, 2020
Napabucasin Drug-Drug Interaction Potential, Safety, Tolerability, and Pharmacokinetics Following Oral Dosing in Healthy Adult Volunteers.
Journal: Clinical pharmacology in drug development
Published: June 15, 2020
Napabucasin versus placebo in refractory advanced colorectal cancer: a randomised phase 3 trial.
Journal: The lancet. Gastroenterology & hepatology
Published: November 15, 2017
Showing 1-5 of 5
Last Updated: 09/26/2026